Clinical Study

Effects of Fasudil on Patients with Pulmonary Hypertension Associated with Left Ventricular Heart Failure with Preserved Ejection Fraction: A Prospective Intervention Study

Table 3

Effect of fasudil on SpO2, NT-pro-BNP, and 6MWD.

VariablePPH (n = 23)RPH (n = 35)
PretreatmentPosttreatmentPretreatmentPosttreatment

SpO2 (%)92.89 ± 3.9793.15 ± 5.130.07191.30 ± 4.6893.07 ± 4.800.052
NT-pro-BNP (ng/ml) (min, max)3664 (789, 21150)1149 (750, 4651)0.0313980 (1312, 24000)1287 (155, 8210)0.004
6MWD (m)361.75 ± 50.24401.34 ± 59.560.042345.60 ± 44.55400.7 ± 59.410.001

Normally distributed data are presented as mean ± standard deviation; nonnormally distributed data are presented as minimum and maximum; normally distributed variables were evaluated using Student’s t-test; nonnormally distributed data were tested by the Wilcoxon test; ; 6MWD, 6-minute walking distance; the change from baseline,.